Streetwise Reports Examines an Immunotherapy Firm That Received a Green Light from FDA for Pivotal Trial – GlobeNewswire (press release)
|
Streetwise Reports Examines an Immunotherapy Firm That Received a Green Light from FDA for Pivotal Trial
GlobeNewswire (press release) SAN FRANCISCO, Dec. 28, 2017 (GLOBE NEWSWIRE) — Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery and will measure its effectiveness in reducing a … |
